Send the following on WhatsApp
Continue to Chathttps://forschung.kssg.ch/en/projects/1025-a-randomized-open-label-phase-3-study-of-sacituzumab-govitecanversus-treatment-of-physicians-choice-in-patients-with-previously-untreated-locally-advanced-inoperable-or-metastatic-triple-negative-breast-cancer-whose-tumors-do-not-express-pd-l1-or-in-patients-previously-treated-with-anti-pd-l1-agents-in-theearly-setting-whose-tumors-do-express-pd-l1